Sanofi and Regeneron's Dupixent approved in EU for chronic spontaneous urticaria

Clearmind Medicine advances global CMND-100 AUD trial with first patient enrolled in Israel

NeuroSense's PrimeC receives FDA clearance for pivotal Phase 3 trial in ALS

Made Scientific enters manufacturing partnership with Cellergy Therapeutics

Novartis' Itvisma granted US FDA approval for spinal muscular atrophy treatment

Xenogenic Materials Demonstrate Promising Results in Peri-Implantitis Management

Tonix Pharmaceuticals receives FDA clearance for Phase 2 study of major depressive disorder treatment

Enlivex Therapeutics reports sustained six-month efficacy for Allocetra in Phase IIa knee osteoarthritis trial

Riyadh's 10th SPNS Conference Focuses on AI and Technology as Catalysts for Better Paediatric Neurology Care

OrthoCarolina Research Institute Marks Major Achievements and Calls for Community Support in Orthopedic Innovation

Inspiring Children Foundation honours NAMI CEO Daniel H Gillison, Jr

AGC Biologics to manufacture AAVantgarde's dual-vector gene therapies for inherited retinal diseases

HitGen signs new funding agreement with Gates Foundation

Nuvalent's zidesamtinib NDA filing accepted by US FDA

Innovent Biologics reports primary and all key secondary endpoints met in mazdutide Phase 3 trial